“Expression of Concern” Over a Green Journal Article
About this episode
Back in March of 2025, the green journal (obstetrics and gynecology) published A systematic review and meta-analysis on 2 medications (non-hormonal) and their efficacy in menopausal hot flash relief period these medications were Fezolinetant and Elinzanetant. However, the editors have just recently released an “Expression of Concern” about this review. Listen in for details.
1. Menegaz de Almeida, Artur MS; Oliveira, Paloma MS; Lopes, Lucca MD; Leite, Marianna MS; Morbach, Victória MS; Alves Kelly, Francinny MD; Barros, Ítalo MS; Aquino de Moraes, Francisco Cezar MS; Prevedello, Alexandra MD. Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-analysis. Obstetrics & Gynecology 145(3):p 253-261, March 2025. | DOI: 10.1097/AOG.0000000000005812
2. Expression of Concern: Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-Analysis. Obstetrics & Gynecology ():10.1097/AOG.0000000000006180, January 16, 2026. | DOI: 10.1097/AOG.0000000000006180
Get every episode summarized
Each time Dr. Chapa's OBGYN No Spin Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Dr. Chapa's OBGYN No Spin Podcast
MS and Pregnancy (Sept 2026 Expert Review)
Dr. Chapa's OBGYN No Spin Podcast
What Defines “Refractory” HTN for Preterm sPreE Delivery?
Dr. Chapa's OBGYN No Spin Podcast
The Cerebellum (TCD) as EGA Referee
Dr. Chapa's OBGYN No Spin Podcast
Parkland Universal LDA (162mg) Preg Study
Dr. Chapa's OBGYN No Spin Podcast